Antibody-based eye drop treatment reduces signs and symptoms of dry eye disease

Researchers at the University of Illinois at Chicago are the first to identify the presence of a specific type of antibody, called anti-citrullinated protein autoantibodies, or ACPAs, in human tear fluid.

From http://besthealthnews.com/2019/10/antibody-based-eye-drop-treatment-reduces-signs-and-symptoms-of-dry-eye-disease/?utm_source=rss&utm_medium=rss&utm_campaign=antibody-based-eye-drop-treatment-reduces-signs-and-symptoms-of-dry-eye-disease

from
https://healthnews010.wordpress.com/2019/10/13/antibody-based-eye-drop-treatment-reduces-signs-and-symptoms-of-dry-eye-disease/

From https://jamesjohnson10.blogspot.com/2019/10/antibody-based-eye-drop-treatment.html

from
https://jamesjohnson10.wordpress.com/2019/10/13/antibody-based-eye-drop-treatment-reduces-signs-and-symptoms-of-dry-eye-disease/

From https://richardwood1.blogspot.com/2019/10/antibody-based-eye-drop-treatment.html

from
https://richardwood1.wordpress.com/2019/10/13/antibody-based-eye-drop-treatment-reduces-signs-and-symptoms-of-dry-eye-disease/